Healthcare Expenditure
Government Investment
- Health expenditure reached 7.2% of GDP in 2024
- Continued increase from previous years
- Commitment to universal coverage expansion
Expenditure Categories
- Public health services
- Hospital infrastructure
- Medical insurance subsidies
- Drug procurement programs
Medical Insurance System
Multi-Tiered Structure
UEBMI (Urban Employees)
- Employer and employee contributions
- Higher reimbursement rates (75-90%)
- Medical savings accounts
URRBMI (Urban-Rural Residents)
- Government subsidies + individual contributions
- Moderate reimbursement rates (60-80%)
- Basic coverage guarantee
Coverage Achievement
- 95%+ population covered by basic insurance
- Remaining gaps being addressed
- Supplementary insurance options available
Payment Reforms
DRG/DIP Systems
Diagnosis-Related Group and Diagnosis-Intervention Packet payment reforms:
- Moving from fee-for-service
- Cost control incentives
- Quality measurement integration
- Nationwide expansion ongoing
Volume-Based Procurement (VBP)
Annual savings exceeding 500 billion yuan:
- Centralized drug purchasing
- Price reductions of 50-70%
- Quality standards maintained
- Generic drug utilization increased
Drug Pricing
National Reimbursement Drug List (NRDL)
- Annual negotiation rounds
- Innovative drugs included
- Average price cuts of 60%+
- Access expansion balanced with sustainability
Commercial Insurance Growth
- Supplementary coverage expansion
- Critical illness products
- International healthcare coverage
- Integration with basic insurance
Financial Sustainability
Challenges
- Aging population pressures
- Rising healthcare costs
- New treatment technologies
- Chronic disease burden
Solutions
- Payment reform implementation
- Procurement efficiency
- Prevention emphasis
- Technology adoption